ISET 2013
New research is being presented at ISET 2013, the 25th Annual International Symposium on...
Read More
Author: PWeekly
FDA Approves Fulyzaq, First Anti-Diarrheal Drug for HIV/AIDS Patients
The U.S. Food and Drug Administration today approved Fulyzaq (crofelemer) to relieve symptoms of...
Read More
FDA Approves Sirturo for Multi-Drug Resistant Tuberculosis
First drug to treat multi-drug resistant tuberculosis On Dec. 28, the U.S. Food and Drug...
Read More
FDA Approves Eliquis Anti-Clotting Drug
The U.S. Food and Drug Administration today approved the anti-clotting drug Eliquis (apixaban), an...
Read More
FDA Approves Juxtapid for Homozygous Familial Hypercholesterolemia
On Dec. 21, the U.S. Food and Drug Administration approved Juxtapid (lomitapide) to reduce...
Read More
FDA Approves Varizig for Reducing Chickenpox Symptoms
The U.S. Food and Drug Administration has approved Varizig for reducing the severity of chicken...
Read More
FDA Expands Tamiflu’s Use to Treat Children Younger than 1 Year
The U.S. Food and Drug Administration today expanded the approved use of Tamiflu (oseltamivir) to...
Read More
FDA Approves Gattex to Treat Short Bowel Syndrome
The U.S. Food and Drug Administration today approved Gattex (teduglutide) to treat adults with...
Read More
Chembio Receives FDA Approval for DPP Point-of-Care HIV 1/2 Rapid Test
Chembio Diagnostics, Inc., a leader in point-of-care diagnostic tests for infectious diseases,...
Read More
FDA Permits Marketing of Bio-Seal Lung Biopsy Tract Plug System
Reduces risk of collapsed lung following lung biopsy The U.S. Food and Drug Administration today...
Read More
FDA Approves Raxibacumab to Treat Inhalational Anthrax
First monoclonal antibody approved using the Animal Efficacy Rule. The U.S. Food and Drug...
Read More
FDA Approves Orphan Drug Signifor for Cushing’s Disease
The U.S. Food and Drug Administration today approved Signifor (pasireotide diaspartate) injection...
Read More
FDA Approves Iclusig to Treat Two Rare Types of Leukemia
Drug approved 3 months ahead of schedule The U.S. Food and Drug Administration today approved...
Read More
FDA Expands Zytiga’s Use for Late-stage Prostate Cancer
Drug can now be used before treatment with chemotherapy The U.S. Food and Drug Administration...
Read More
FDA Approves Cometriq to Treat Rare Type of Thyroid Cancer
The U.S. Food and Drug Administration today approved Cometriq (cabozantinib) to treat medullary...
Read More
FDA Approves First Seasonal Influenza Vaccine Manufactured Using Cell Culture Technology
The U.S. Food and Drug Administration announced today the approval of Flucelvax, the first...
Read More
FDA Approves Pump for Heart Failure Patients Awaiting Heart Transplant
The U.S. Food and Drug Administration today approved the HeartWare Ventricular Assist System, a...
Read More
2012 VEITHsymposium: Pros and Cons of Multilayer Stent Technology to be Debated
Belgian Device Being Marketed in E.U., Still Awaiting U.S. Approval. The multilayer stent system...
Read More
2012 VEITHsymposium: New Medicines, New Technologies Provide Vascular Surgeons Expanded Options for Treatment of Pulmonary Embolism
Vascular specialists are heralding a variety of advances in the treatment of pulmonary embolism...
Read More
2012 VEITHsymposium: New Techniques and New Technologies in the Endovascular Arena
New techniques and endovascular technologies will be in the spotlight during the 39th annual...
Read More